Effects of Huoxin Prescription on Therapeutic Efficacy of Angina Pectoris of Coronary Heart Disease and Serum Level of VEGF

ZHANG Chao; YAO Cheng-zeng; JIANG Mei-xian; HU Qi-xiang; GUAN Jing-shu; CAO Fei

doi:10.13422/j.cnki.syfjx.2014160180

您当前的位置：

首页 >

文章列表页 >

Effects of Huoxin Prescription on Therapeutic Efficacy of Angina Pectoris of Coronary Heart Disease and Serum Level of VEGF

更新时间：2024-01-04

- Effects of Huoxin Prescription on Therapeutic Efficacy of Angina Pectoris of Coronary Heart Disease and Serum Level of VEGF
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 20, Issue 16, Pages: 180-183(2014)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.2014160180
  CLC： R259
- Published：2014
- 稿件说明：
移动端阅览
ZHANG Chao, YAO Cheng-zeng, JIANG Mei-xian, et al. Effects of Huoxin Prescription on Therapeutic Efficacy of Angina Pectoris of Coronary Heart Disease and Serum Level of VEGF[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(16): 180-183.
DOI：

ZHANG Chao, YAO Cheng-zeng, JIANG Mei-xian, et al. Effects of Huoxin Prescription on Therapeutic Efficacy of Angina Pectoris of Coronary Heart Disease and Serum Level of VEGF[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(16): 180-183. DOI： 10.13422/j.cnki.syfjx.2014160180.

摘要

目的：观察中药活心方加载治疗对冠心病心绞痛患者的临床疗效及血清血管内皮生长因子（VEGF）水平的影响。方法：将60例冠心病心绞痛患者随机分为两组，中药加载组（n=31）和对照组（n=29）；对照组采用西药常规治疗，中药加载组在西药常规治疗的基础上给予活心方加载治疗。对两组患者的中医证候疗效、心绞痛疗效、左室射血分数（LVEF）及血清VEGF水平进行观测。结果：经治疗后，与对照组相比，中药加载组患者的中医证候积分进一步降低（P<0.05），中医证候疗效和心绞痛疗效总有效率更高（P<0.05）；与治疗前相比，中药加载组患者治疗后LVEF及血清VEGF水平得以提高（P<0.05，P<0.01），而对照组无显著性变化，治疗后组间有显著差异（P<0.05）。结论：活心方加载治疗可进一步改善冠心病心绞痛患者的临床症状，提高临床疗效，并增加患者LVEF和提高其血清VEGF水平。

Abstract

Objective: To observe the effects of Huoxin prescription on therapeutic efficacy of angina pectoris of coronary heart disease and serum level of vascular endothelial growth factor(VEGF). Method: Sixty patients with angina pectoris were randomly assigned into traditional Chinese medicine(TCM) group (31 patients) and control group (29 patients). All the patients involved were treated with western medicine

and the patients in TCM group were given the Chinese medicine

Huoxin prescription

in addition. Then we observed the therapeutic efficacy of the TCM syndrome and angina pectoris

left ventricular ejection fraction (LVEF) and serum level of VEGF. Result: Compared with the control group

TCM syndrome score of the patients in TCM group was further decreased(P<0.05)

and the total efficiency of TCM syndrome and angina pectoris were higher(P<0.05). Compared with before treatment

the LVEF and serum level of VEGF of the patients in TCM group were increased(P<0.05

P<0.01)

and there were significant differences between the two groups after treatment(P<0.05). Conclusion: The symptoms of the patients in TCM group were further improved by treating with Huoxin prescription

and the therapeutic efficacy was further increased as well. Simultaneously

the LVEF and serum level of VEGF of the patients in TCM group were increased by treatment of Huoxin prescription.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Mechanism of Kidney-tonifying and Liver-regulating Cyclical Therapy and Formula in Improving Endometrial Receptivity during "Implantation Window" in Rats with Polycystic Ovary Syndrome via miR-140-5p/VEGF Pathway

Protective Effect of Taohong Siwutang on Cerebral Ischemia-reperfusion Injury Based on A1/A2 Phenotype Transformation of Astrocytes Mediated by JAK2/STAT3 Pathway

Clinical Comprehensive Evaluation of Guanxinjing Capsules in Treating Angina Pectoris of Coronary Heart Disease with Syndrome of Qi Deficiency and Blood Stasis in "6+1" Dimensions

Effect of Xiao Xianxiongtang on 5-FU-mediated Myocardial Fibrosis and Protein Expression of HIF-1α/VEGF Signaling Pathway in Mice

Effect of Component Compatibility of Gentianae Macrophyllae Radix and Clematidis Radix et Rhizoma on Serum Inflammatory Factors and Expression of NF-κB and VEGF in Ankle Joint of Rats with Rheumatoid Arthritis

Related Author

LIU Quan

HE Yiqing

ZHANG Ying

WANG Xi

YANG Shuo

WANG Huifang

CHEN Xinru

CHEN Mengyuan

Related Institution

Key Laboratory of Hunan Province for Integrated Traditional Chinese and Western Medicine on Prevention and Treatment of Cardio-Cerebral Diseases， Hunan University of Chinese Medicine

Hunan University of Chinese Medicine

MOE-Anhui Joint Collaborative Innovation Center for Quality Improvement of Anhui Genuine Chinese Medicinal Materials

Anhui Province Key Laboratory of Chinese Medicinal Formula

School of Pharmacy，Anhui University of Chinese Medicine

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰